Qian Xin

Animal Models of Acute lymphoblastic leukemia: recapitulating the human disease to evaluate drug efficacy and discover therapeutic targets.

Wei Wei, Yu-jing Wu, Qian Xin, 2022, Biochemical pharmacology.

An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis

Wei Wei, Jingyu Chen, Aijun Zhang, 2021, Acta Pharmacologica Sinica.

IgD enhances the release of neutrophil extracellular traps (NETs) via FcδR in rheumatoid arthritis patients.

Jing Xu, Wei Wei, Tao Li, 2022, International immunopharmacology.

An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis

Jingyu Chen, Lingling Zhang, Yan Chang, 2021, Acta Pharmacologica Sinica.

IgD/FcδR is involved in T-cell acute lymphoblastic leukemia and regulated by IgD-Fc-Ig fusion protein.

Tao Li, Jian Ge, Jing Zhang, 2023, Pharmacological research.

The pathogenesis and development of targeted drugs in acute T lymphoblastic leukaemia

Qian Xin, Zhaoying Chen, Yujing Wu, 2023, British journal of pharmacology.

CAR-T therapy for ovarian cancer: Recent advances and future directions.

Yizhao Chen, Qian Xin, Xiaojing Sun, 2024, Biochemical pharmacology.